NCT04310059View on ClinicalTrials.gov

Effect of Folic Acid Supplementation in Pregnant Women Having Thalassaemia Trait

NANot yet recruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions
ThalassemiaFolic Acid Deficiency Anemia
Interventions
DIETARY_SUPPLEMENT

Folic acid

women will be randomised into one of the three groups. Group A - Folic acid 5mg/day Group B - Folic acid 0.5mg/day Group C - Materna one tablet/day (a pregnancy supplement containing 0.6mg folic acid)

DIETARY_SUPPLEMENT

Materna

Materna

All Listed Sponsors
collaborator

Queen Mary Hospital, Hong Kong

OTHER

lead

The University of Hong Kong

OTHER

NCT04310059 - Effect of Folic Acid Supplementation in Pregnant Women Having Thalassaemia Trait | Biotech Hunter | Biotech Hunter